Stereotaxis (STXS) Cash from Financing Activities (2010 - 2026)

Stereotaxis (STXS) reported Cash from Financing Activities of $4.7 million for Q1 2026, up 14637.5% year-over-year from N/an in Q1 2025, and down 32.18% quarter-over-quarter from $7.0 million in Q4 2025.

Stereotaxis (STXS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Cash from Financing Activities data on file, last reported at $4.7 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $4.7 million, up 14637.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.4 million (up 6404.01% YoY), and the FY2025 annual result was $14.8 million, up 4870.71% from the prior year.
  • Cash from Financing Activities slipped to $4.7 million in Q1 2026 per STXS's latest filing, from $7.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $7.7 million in Q3 2025 and troughed at -$26000.0 in Q2 2023.
  • A 5-year average of $1.2 million and a median of $54000.0 in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2026: Cash from Financing Activities slumped 145.61% in 2023, then surged 14637.5% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $61000.0 in 2022, then tumbled by 57.38% to $26000.0 in 2023, then soared by 511.54% to $159000.0 in 2024, then jumped by 4273.58% to $7.0 million in 2025, then tumbled by 32.18% to $4.7 million in 2026.
  • Business Quant data shows STXS's Cash from Financing Activities at $4.7 million in Q1 2026, $7.0 million in Q4 2025, and $7.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Stereotaxis 180.48 Mn 165.86 Mn 3.79 Mn 4.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.72 Mn
Mar 31, 2026 4.72 Mn
Dec 31, 2025 6.95 Mn
Dec 31, 2025 6.95 Mn
Sep 30, 2025 7.74 Mn
Sep 30, 2025 7.74 Mn
Jun 30, 2025 34,000.00
Jun 30, 2025 34,000.00
Mar 31, 2025 32,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 159,000.00
Dec 31, 2024 159,000.00
Sep 30, 2024 80,000.00
Sep 30, 2024 80,000.00
Jun 30, 2024 28,000.00
Jun 30, 2024 28,000.00
Mar 31, 2024 30,000.00
Mar 31, 2024 30,000.00
Dec 31, 2023 26,000.00
Dec 31, 2023 26,000.00